Is HEXO (TSX:HEXO) Stock a Buy After a 40% Pullback?

HEXO Corp. (TSX:HEXO) is down nearly 40% in less than two months. Is the pullback overdone?

| More on:
Man holding magnifying glass over a document

Image source: Getty Images.

Shares of HEXO (TSX:HEXO) are down nearly 40% from the April high, and investors who missed the big rally to start the year are wondering if the pullback is an opportunity to start a new position in the popular marijuana stock.

Let’s take a look at the current situation to see if HEXO deserves to be on your buy list.

Market outlook

The emerging cannabis sector has been on a wild ride in the past three years as players compete to secure footholds in key developing markets while keeping a high enough domestic profile to attract the capital needed to expand production.

The recent volatility aside, HEXO has been a pretty good investment in its short lifetime. The stock was $0.50 three years ago and drifted steadily higher to about $5.50 at the end of last summer before the entire sector rocketed higher ahead of the launch of the recreational marijuana market in Canada. HEXO hit $8.75 near the end of September before sliding with its peers through the next couple of months until it bottomed out in late December around $4.31.

The 2019 rally took it to a high above $11 amid a new wave of optimism in the sector. Part of that came as a result of the broad-based recovery in equity markets. Investors also thought the issues that caused the slow start to the recreational market would be resolved by the middle of this year, but growing pains remain.

In addition, there might have been a surge due to enthusiasm around the upcoming launch of the marijuana edibles market.

Should you buy HEXO?

Ongoing volatility should be expected, and there is a chance that the stock could extend the recent slide before we see a new rally. That said, investors who like the long-term outlook for the cannabis industry might want to start nibbling on the stock.

HEXO is the leading player in Quebec, and its acquisition of Newstrike expanded its supply agreements to eight provinces. In addition, HEXO and its partner Molson Coors Canada are making progress on the development of cannabis-infused drinks for the upcoming market opening. If the drink business takes off as expected, the stock could get a big boost in 2020.

At the current price, HEXO has a market capitalization of about $1.75 billion. The company might become a takeover target as consolidation continues among the marijuana players. The head start on the drinks business and the stronghold position in Quebec should make HEXO an appealing acquisition. Whether an offer will come at a big premium is anyone’s guess, but investors shouldn’t rule out the possibility.

If you are a marijuana bull, HEXO might be an interesting contrarian pick today.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Andrew Walker has no position in any stock mentioned.

More on Cannabis Stocks

edit Jars of marijuana
Cannabis Stocks

Is Tilray Stock a Buy in the New Bullish Market?

Canadian cannabis producer Tilray has underperformed the broader markets in the last five years due to its weak fundamentals.

Read more »

Bad apple with good apples
Cannabis Stocks

1 TSX Stock I Wouldn’t Touch With a 10-Foot Pole

Down 99% from all-time highs, Aurora Cannabis stock remains a high-risk bet due to its weak fundamentals and risky liquidity…

Read more »

A cannabis plant grows.
Cannabis Stocks

Canopy Growth Stock Has Been on a Roller Coaster: Is it a Good Buy?

In their relatively small lifetime, most cannabis stocks in Canada have seen both extreme highs and massive slumps. But their…

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Canopy Growth Stock Surged 100% Last Month: Is It a Good Buy Now?

Canopy Growth soared more than 160% last month. Can the TSX cannabis stock continue to mover higher in 2024?

Read more »

A cannabis plant grows.
Cannabis Stocks

Canopy Growth Stock Is Rising But I’m Worried About This One Thing

Canopy Growth stock is soaring as the legalization effort makes real progress in both Germany and the United States.

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Why Canopy Growth Stock Could Double in 2024

Canopy Growth (TSX:WEED) stock saw its share more than double in the last two weeks. So, can it do it…

Read more »

Coworkers standing near a wall
Cannabis Stocks

Why Is Everyone Talking About Canopy Growth Stock?

Canopy Growth stock (TSX:WEED) saw shares surge in the last two weeks for a variety of reasons investors can dig…

Read more »

Pot stocks are a riskier investment
Stocks for Beginners

Why Shares of Cannabis Stocks Are Rising This Week

Cannabis stocks received a boost this week as the White House urged the drug enforcement administration to reschedule the drug.

Read more »